Q-omics provides the consensus-scored RNU1-62P profile across patient tissues and cancer cell-line models. RNU1-62P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in BRCA. Additionally, RNU1-62P RNA expression shows 5,785 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight BRCA as cancer lineages where RNU1-62P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.